L & S Advisors Inc Aerie Pharmaceuticals Inc Transaction History

L & S Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$15.16 - $18.97 $189,500 - $237,125	-12,500 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$13.12 - $20.9 $164,000 - $261,249	12,500 New	12,500 $223,000
Q4 2018 Feb 14, 2019	SELL	$33.0 - $60.04 $165,825 - $301,701	-5,025 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$56.15 - $73.9 $11,230 - $14,780	200 Added 4.15%	5,025 $309,000
Q2 2018 Aug 13, 2018	BUY	$47.85 - $70.45 $230,876 - $339,921	4,825 New	4,825 $326,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of L & S Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on L & S Advisors Inc with notifications on news.